• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向结核病:抑制细胞色素氧化酶的新型支架。

Targeting Tuberculosis: Novel Scaffolds for Inhibiting Cytochrome Oxidase.

机构信息

Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California 92093, United States.

Department of Chemical Engineering, University of California, Davis, Davis, California 95616, United States.

出版信息

J Chem Inf Model. 2024 Jul 8;64(13):5232-5241. doi: 10.1021/acs.jcim.4c00344. Epub 2024 Jun 14.

DOI:10.1021/acs.jcim.4c00344
PMID:38874541
Abstract

Discovered in the 1920s, cytochrome is a terminal oxidase that has received renewed attention as a drug target since its atomic structure was first determined in 2016. Only found in prokaryotes, we study it here as a drug target for (). Most previous drug discovery efforts toward cytochrome have involved analogues of the canonical substrate quinone, known as Aurachin D. Here, we report six new cytochrome inhibitor scaffolds determined from a computational screen and confirmed on target activity through testing. These scaffolds provide new avenues for lead optimization toward therapeutics.

摘要

细胞色素 c 是一种末端氧化酶,于 20 世纪 20 年代被发现,自 2016 年其原子结构首次被确定以来,它作为药物靶点重新引起了人们的关注。细胞色素 c 仅存在于原核生物中,我们在这里将其作为 () 的药物靶点进行研究。以前大多数针对细胞色素 c 的药物发现工作都涉及经典底物醌的类似物,称为 Aurachin D。在这里,我们报告了从计算筛选中确定的六个新的细胞色素 c 抑制剂支架,并通过 () 测试证实了其靶标活性。这些支架为开发 () 治疗药物的先导化合物优化提供了新途径。

相似文献

1
Targeting Tuberculosis: Novel Scaffolds for Inhibiting Cytochrome Oxidase.靶向结核病:抑制细胞色素氧化酶的新型支架。
J Chem Inf Model. 2024 Jul 8;64(13):5232-5241. doi: 10.1021/acs.jcim.4c00344. Epub 2024 Jun 14.
2
Discovery of 1-hydroxy-2-methylquinolin-4(1H)-one derivatives as new cytochrome bd oxidase inhibitors for tuberculosis therapy.发现 1-羟基-2-甲基喹啉-4(1H)-酮衍生物作为治疗结核病的新型细胞色素 bd 氧化酶抑制剂。
Eur J Med Chem. 2023 Jan 5;245(Pt 1):114896. doi: 10.1016/j.ejmech.2022.114896. Epub 2022 Nov 4.
3
Discovery of novel InhA reductase inhibitors: application of pharmacophore- and shape-based screening approach.新型 InhA 还原酶抑制剂的发现:基于药效团和形状的筛选方法的应用。
Future Med Chem. 2013 Mar;5(3):249-59. doi: 10.4155/fmc.12.211.
4
Development of benzo[d]oxazol-2(3H)-ones derivatives as novel inhibitors of Mycobacterium tuberculosis InhA.苯并[d]恶唑-2(3H)-酮衍生物作为结核分枝杆菌InhA新型抑制剂的开发
Bioorg Med Chem. 2014 Nov 1;22(21):6134-45. doi: 10.1016/j.bmc.2014.08.031. Epub 2014 Sep 4.
5
Arylvinylpiperazine Amides, a New Class of Potent Inhibitors Targeting QcrB of Mycobacterium tuberculosis.芳基乙烯基哌嗪酰胺,一种针对结核分枝杆菌 QcrB 的新型强效抑制剂。
mBio. 2018 Oct 9;9(5):e01276-18. doi: 10.1128/mBio.01276-18.
6
Biological evaluation of potent triclosan-derived inhibitors of the enoyl-acyl carrier protein reductase InhA in drug-sensitive and drug-resistant strains of Mycobacterium tuberculosis.结核分枝杆菌药敏和耐药菌株中强效三氯生衍生的烯酰-酰基载体蛋白还原酶InhA抑制剂的生物学评价
ChemMedChem. 2014 Nov;9(11):2528-37. doi: 10.1002/cmdc.201402255. Epub 2014 Aug 27.
7
First triclosan-based macrocyclic inhibitors of InhA enzyme.首款基于三氯生的 InhA 酶大环抑制剂。
Bioorg Chem. 2020 Jan;95:103498. doi: 10.1016/j.bioorg.2019.103498. Epub 2019 Dec 6.
8
Novel targets and inhibitors of the cytochrome oxidase to foster anti-tuberculosis drug discovery.新型细胞色素氧化酶靶标和抑制剂促进抗结核药物研发。
Expert Opin Drug Discov. 2023 Jul-Dec;18(8):917-927. doi: 10.1080/17460441.2023.2224553. Epub 2023 Jun 18.
9
Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis.抗结核化合物库筛选鉴定出新型结核分枝杆菌ATP合酶抑制剂。
Tuberculosis (Edinb). 2018 Jan;108:56-63. doi: 10.1016/j.tube.2017.10.008. Epub 2017 Oct 25.
10
Discovery of novel acetohydroxyacid synthase inhibitors as active agents against Mycobacterium tuberculosis by virtual screening and bioassay.通过虚拟筛选和生物测定发现新型乙酰羟酸合酶抑制剂作为抗结核分枝杆菌的活性物质。
J Chem Inf Model. 2013 Feb 25;53(2):343-53. doi: 10.1021/ci3004545. Epub 2013 Jan 30.

引用本文的文献

1
Carbon Monoxide and Prokaryotic Energy Metabolism.一氧化碳与原核生物能量代谢
Int J Mol Sci. 2025 Mar 20;26(6):2809. doi: 10.3390/ijms26062809.
2
A quantitative analysis of ligand binding at the protein-lipid bilayer interface.蛋白质-脂质双层界面处配体结合的定量分析。
Commun Chem. 2025 Mar 22;8(1):89. doi: 10.1038/s42004-025-01472-8.
3
Breaking the energy chain: importance of ATP synthase in and its potential as a drug target.打破能量链:ATP合酶的重要性及其作为药物靶点的潜力。
RSC Med Chem. 2025 Jan 8. doi: 10.1039/d4md00829d.